| abstract |
The present invention relates to novel polypeptides, herein designated EG-VEGF, and nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising the nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the invention fused to heterologous polypeptide sequences, polypeptides of the invention, Antibodies that bind and methods for producing the polypeptides of the invention. Also provided herein is a method of screening for a modulator of EG-VEGF. Furthermore, methods of treatment and related methods relating to controlling cell proliferation and chemotaxis are described herein. |